Mathew
but here is the twist. the company knows by amending the deal to remove the offering before 31/3 , to have cash equivalent of 8 months , why would they offer this deal when its impossible for the company ?
only if the company has sorted another way of funding.
Thoratec paid $3m for a board observer 3 years back.
Distribution rights will fetch over $5m.
Ideally , the company will have a deal sorted. Push with more enrollments. Once the stock price is $5 or more have an offering of 7m shares. I say 7 as to have a round # of $25m o/s which isnt much. and considering the circumstances ill take that.
Also , if Cpulse 2 is granted expedited approval which is highly likely. The company's burn rate will be much greater than current levels. Meaning we will need more money.
Were all in the same boat. Either we lose it all or go on to a big winner. My only advice , if you can buy just close your eyes and buy. I have bought at every level possible and this still declines but I do know , if hopefully this goes back up again , I would be in a much much better position than a year ago.
All the best.
- Forums
- ASX - By Stock
- SHC
- C-Pulse Worth more than Facebook
C-Pulse Worth more than Facebook, page-17
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online